This past winter has been unusually dry and warm across the Tetons, with lower-than-average snowpack. As we move into the ...

THIS fantastic picture of the view towards Whitehope Rig at the top of the Yarrow Valley was taken by reader John Smail.

A stalwart Park City hotel will close temporarily in coming days for a major renovation that is expected to stretch for up to a year.

Thank you for signing up! Did you know with a Digital Subscription to Lancashire Evening Post, you can get unlimited access to the website including our premium content, as well as benefiting from ...

Families looking for something to do this February half term are being urged to make the most of a rare spell of sunshine - with forecasters predicting bright conditions despite the winter chill.

Keeping the kids busy during February half term is always a challenge, especially when the weather is so hit and miss. Fortunately there are lots of things to do across Greater Manchester this week ...

African Muslim Yarrow Mamout rose from a life of slavery to become a popular businessman in Washington, D.C. Artist Charles Willson Peale painted his portrait and discovered his incredible story.

AAIB investigation to Aerotechnik EV-97 Eurostar, G-TIVV: Hard landing, Yarrow Valley, Scottish Borders, 17 May 2017. The incident was the subject of an AAIB Investigation, and the following is the ...

Vyne Therapeutics is set to combine with Yarrow Bioscience in an all-stock merger. Vyne, a clinical-stage biopharmaceutical company, and Yarrow Bioscience, a clinical-stage biotechnology company said ...

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE”) and Yarrow Bioscience, Inc. (“Yarrow”) today announced that they have entered into a definitive merger ...

Following closing, combined company plans to progress Yarrow’s lead program, YB-101, a potentially first-in-class anti-thyroid-stimulating hormone receptor (“TSHR”) antibody for Graves’ disease (“GD”) ...

U.S.-based Yarrow Bioscience is branching out, picking an autoimmune thyroid disease drug from China as its lead candidate. Through a potential $1.37 billion deal, New York-headquartered Yarrow gains ...